Compare BIO & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIO | MIR |
|---|---|---|
| Founded | 1952 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Industrial Machinery/Components |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 6.2B |
| IPO Year | N/A | N/A |
| Metric | BIO | MIR |
|---|---|---|
| Price | $278.96 | $21.56 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 8 |
| Target Price | ★ $358.50 | $28.38 |
| AVG Volume (30 Days) | 289.2K | ★ 3.7M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.31 | $23.84 |
| Revenue Next Year | $3.10 | $7.59 |
| P/E Ratio | ★ $9.72 | $195.00 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $211.43 | $12.00 |
| 52 Week High | $343.12 | $30.28 |
| Indicator | BIO | MIR |
|---|---|---|
| Relative Strength Index (RSI) | 45.27 | 40.75 |
| Support Level | $266.71 | $19.40 |
| Resistance Level | $290.01 | $22.53 |
| Average True Range (ATR) | 9.32 | 1.03 |
| MACD | 0.34 | -0.02 |
| Stochastic Oscillator | 57.28 | 27.89 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.